ARTICLESRandomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease
References (10)
- et al.
Non-invasive ventilatory support during sleep improves respiratory failure in kyphoscoliosis
Chest
(1988) - et al.
Nasal positive pressure ventilation in patients with acute respiratory failure is a difficult and time-consuming procedure for nurses
Chest
(1991) - et al.
Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management
Thorax
(1992) - et al.
Treatment of acute respiratory acidosis in chronic obstructive lung disease
JAMA
(1971)
There are more references available in the full text version of this article.
Cited by (804)
Mortality in individuals with COPD on long-term home non-invasive ventilation
2023, Respiratory MedicineThe physiology and pathophysiology of exercise hyperpnea
2022, Handbook of Clinical NeurologyDyspnea in Patients Receiving Mechanical Ventilation
2021, Encyclopedia of Respiratory Medicine, Second EditionNon-Invasive Ventilation in Acute, Post-Acute and Stable COPD
2021, Encyclopedia of Respiratory Medicine, Second EditionOxygen Therapy and Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease
2020, Clinics in Chest MedicineCitation Excerpt :From a clinical point of view, NIV is indicated in patients with COPD for the treatment of acute, chronic, and acute-on-chronic hypercapnic respiratory failure (Fig. 1, Table 9). Use of NIV in this setting has been shown to reduce Paco2 and increase pH.52 More significantly, in addition to standard therapy, NIV improves dyspnea during COPD exacerbation, reduces mortality, decreases the need for endotracheal intubation, and shortens the length of the hospital stay.52,53 Therefore, NIV is usually the first-line treatment option in patients with acute hypercapnic respiratory failure due to COPD who need mechanical ventilation; use of NIV avoids the side effects of invasive ventilation.
Copyright © 1993 Published by Elsevier Ltd.